TABLE 2.
Antimicrobial susceptibility of K. pneumoniae isolated from patients with bacteremia in 12 hospitals in China, 2016–2018
| Antibiotics | MIC50 | %S | %I | %R |
|---|---|---|---|---|
| Piperacillin-tazobactam | >128 | 6.8 | 0.7 | 92.5 |
| Cefoxitin | >32 | 1.4 | 2.0 | 96.6 |
| Cefotaxime | >64 | 0.7 | 1.4 | 97.9 |
| Ceftazidime | >32 | 1.4 | -a | 98.6 |
| Cefepime | >16 | 1.4 | - | 98.6 |
| Aztreonam | >32 | 4.5 | - | 92.5 |
| Imipenem | >16 | 1.4 | 0.7 | 97.9 |
| Meropenem | >16 | 0.0 | 0.0 | 100.0 |
| Ceftazidime-Avibactam | 2 | 74.8 | - | 25.2 |
| Polymyxin B | ≤0.5 | - | 96.6 | 3.4 |
| Ciprofloxacin | >4 | 13.6 | 5.4 | 80.1 |
| Gentamicin | >16 | 31.3 | 2.7 | 66.0 |
| Amikacin | >64 | 49.0 | - | 51.0 |
| Tetracycline | >16 | 40.1 | 6.8 | 53.1 |
| Minocycline | 8 | 17.0 | 15.0 | 68.0 |
| Tigecycline | 2 | 73.5 | 21.1 | 5.4 |
| Trimethoprim/sulfamethoxazole | >2 | 45.6 | - | 54.4 |
a
-, means negative.